| abstract |
OF THE DISCLOSURE nThe present invention relates to compounds of formula I: nN---N NH R2 nF3C / O 0 N4 nN Rn1 R 3 nCF 3 (I nand pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising the ncompounds of formula I, and methods of using said compounds, salts and compositions in the ntreatment of various disorders associated with CRM1 activity. |